Table 3 Growth hormone therapy use among 165 study participants with Prader-Willi syndrome
|  | 12–17 years old, n (%) | 18 years or older, n (%) | Total |
|---|---|---|---|
Currently on Growth Hormone* | |||
 Yes | 69 (78.4) | 29 (37.7) | 98 (59.4) |
 No | 19 (21.6) | 48 (62.3) | 67 (40.6) |
Ever on Growth Hormone* | |||
 Yes | 82 (93.2) | 56 (72.7) | 138 (83.6) |
 No | 6 (6.8) | 21 (27.3) | 27 (16.4) |
Number of Years on GH Therapy, mean + SD | 9.82 + 4.67 | 9.15 + 8.11 | 9.51 + 6.48 |
Percentage of Life on GH Therapy, mean + SD* | 70.5% + 32.9% | 40.8% + 36.7% | 56.7% + 37.7% |